Benzinga · Aug 14, 2026
Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.
HI
NASDAQ · HIT
Health In Tech, Inc.
Technology · Software - Application
$0.94
Up+$0.01 (+0.57%)
Updated Sep 10, 2026, 2:57 AM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 60.6M
- P/E ratio
- 41.82
- Dividend yield
- 0.00%
- 52-week range
- $0.85 – $4.02
- Volume
- 47.97K
- Avg. volume
- 448.77K
Price performance
HIT price history
1M range · 20 trading sessions · Daily adjusted prices
HIT closed at $0.94 after 20 trading sessions, down 8.19% for the selected period.
- Last close
- $0.94
- Period change
- -8.19%
- Period low
- $0.93
- Period high
- $1.06
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $0.93 | $0.9803 | $0.9251 | $0.9365 | 47.97K |
| Sep 8, 2026 | $0.9522 | $0.9999 | $0.93 | $0.9312 | 95.93K |
| Sep 4, 2026 | $0.98 | $0.9995 | $0.9711 | $0.9801 | 21.22K |
| Sep 3, 2026 | $0.97 | $1.00 | $0.945 | $0.9994 | 57.15K |
| Sep 2, 2026 | $0.97 | $0.9999 | $0.94 | $0.9762 | 34.14K |
| Sep 1, 2026 | $0.97 | $0.9799 | $0.9394 | $0.968 | 37.31K |
| Aug 31, 2026 | $0.98 | $0.9899 | $0.96 | $0.96 | 46.42K |
| Aug 28, 2026 | $0.981 | $1.02 | $0.971 | $0.98 | 64.93K |
| Aug 27, 2026 | $0.98 | $1.02 | $0.955 | $1.0002 | 11.4K |
| Aug 26, 2026 | $0.9928 | $1.025 | $0.98 | $1.01 | 30.55K |
| Aug 25, 2026 | $0.97 | $1.03 | $0.9601 | $1.01 | 37.28K |
| Aug 24, 2026 | $0.99 | $0.9999 | $0.955 | $0.97 | 33.27K |
| Aug 21, 2026 | $0.9906 | $1.03 | $0.96 | $1.00 | 66.8K |
| Aug 20, 2026 | $0.9991 | $1.02 | $0.99 | $1.02 | 21.15K |
| Aug 19, 2026 | $0.9902 | $1.03 | $0.9901 | $1.03 | 150.38K |
| Aug 18, 2026 | $1.02 | $1.03 | $0.99 | $1.00 | 168.11K |
| Aug 17, 2026 | $0.9848 | $1.015 | $0.975 | $1.01 | 133.81K |
| Aug 14, 2026 | $1.00 | $1.01 | $0.98 | $1.005 | 302.91K |
| Aug 13, 2026 | $1.03 | $1.13 | $1.03 | $1.06 | 122.67K |
| Aug 12, 2026 | $1.05 | $1.07 | $1.00 | $1.02 | 77.2K |
Latest HIT news
The latest Smart Investors Daily articles mentioning HIT.
Stock researchCompany · Overview
HIT research
Overview
Company profile and research snapshot.
Company profile
Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | Maxim Group | Buy | — |
| Apr 20, 2026 | Craig-Hallum | Buy | — |
| Jun 26, 2025 | Maxim Group | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 13, 2026
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call Transcript
Health In Tech, Inc. (HIT) Q2 2026 Earnings Call August 13, 2026 5:00 PM EDTCompany ParticipantsLori Babcock - Chief of StaffTim Johnson - Founder, CEO...
SeekingAlpha · Aug 13, 2026
Health In Tech, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-13. The following slide deck was published by Health In Tech, Inc.
Benzinga · Aug 13, 2026
Health In Tech Q2 2026 Earnings Call: Complete Transcript
Health In Tech (NASDAQ:HIT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
